ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1231

The Quality Of Life and Resource Use Related To Hip Fractures Based On Data From The International Costs and Utilities Related To Osteoporotic Fractures Study

Moa Ivergård1, Viktor Wintzell1, László B Tankó2, Victoria Barghout3, Axel Svedbom1, Vidmantas Alekna4, Maria Luisa Bianchi5, Patricia Clark6, Manuel Díaz Curiel7,8, Hans Peter Dimai9, Mikk Jürisson10, Olga Lesnyak11, Eugene McCloskey12, Kerrie M Sanders13, Thierry Thomas14, Fredrik Borgström15 and John A Kanis16, 1OptumInsight, Stockholm, Sweden, 2Novartis Pharma AG, Basel, Switzerland, 3VEB HealthCare, Morristown, NJ, 4Vilnius University, Faculty of Medicine, Vilnius, Lithuania, 5Bone Metabolism Unit, Istituto Auxologico Italiano IRCCS, Milan, Italy, 6Clinical Epidemiology Unit, Hospital Infantil Federico Gómez and Faculty of Medicine UNAM, Mexico City, Mexico, 7Servicio de Medicina Interna/Enfermedades Metabolicas Osea, Fundacion Jimenez Diaz, Madrid, Spain, 8Catedra de Enfermedades Metabolicas Óseas, Universidad Autonoma, Madrid, Spain, 9Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria, 10Department of Public Health, Faculty of Medicine, Tartu University, Tartu, Estonia, 11Ural State Medical Academy, Yekaterinburg, Russia, 12Academic Unit of Bone Metabolism, Metabolic Bone Centre, University of Sheffield, Sheffield, United Kingdom, 13Department of Medicine, NorthWest Academic Centre, The University of Melbourne, Melbourne, Australia, 14INSERM U1059, CHU-St-Etienne, Saint Etienne, France, 15LIME/MMC, Karolinska Institutet, Stockholm, Sweden, 16WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: fractures, Hip, osteoporosis and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease: Clinical Aspects and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: The International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS) is an ongoing 18 months prospective observational study with the objective of estimating resource use and health related quality of life (HRQoL) related to osteoporotic fractures. This study aims to describe the resource utilization for hip fractures pooled from 10 countries (Australia, Austria, Estonia, France, Italy, Lithuania, Mexico, Russia, Spain and the UK).

Methods: We studied 2,407 patients with low-energy hip fracture sustained from 2007 to 2012. For the purpose of the present study patients had to be ≥ 50 years, live in their own home prior to the fracture, and have had the first study interview within 2 weeks after fracture. Data were collected through patient interviews and review of medical records in four phases (at baseline, Month 4, 12, and 18). Key data included patient reported HRQoL (EQ-5D), and resource utilization due to the fracture. HRQoL before fracture was collected immediately after fracture.  Patients with complete data at each follow-up were included in the analyses. The EQ-5D is a HRQoL instrument consisting five dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression) with 243 possible response combinations. These health states can be translated into health utilities on a unison scale using UK population based preference values (range -0.59 to 1; 1 for full health, 0 for dead, below 0 for health states worse than dead) [1].

Results:  There were 1795, 1435, 1256 patients available for analysis at the 4, 12 and 18 months follow-up, respectively. The mean age (±SD) at fracture was 77±10 years and 79% were women. Emergency or traumatology departments were the first point of contact with the healthcare system for 89% of patients. 96% of patients were hospitalized and the mean hospital length of stay due to the fracture (±SD) was 17.2±20.4 days. During the first four months after fracture, the mean number of physician, nurse and physiotherapy visits related to the fracture were estimated at 2.8±3.1, 2.4±9.6, and 8.2±13 respectively. During the same time period, 65% of patients used analgesics, 41% calcium/vitamin D, and 27% pharmacological interventions for osteoporosis. The mean utility was 0.75±0.28 before fracture, -0.13±0.37 after fracture, 0.48±0.39 at Month 4, 0.58±0.37 at Month 12, and 0.66±0.36 at Month 18 following the fracture.

Conclusion: Hip fractures were associated with severe immediate loss in HRQoL. The mean health utility was estimated at -0.13 directly after fracture, which is worse than death on the 0 (death) to 1 (full health) scale. Whereas patients gradually recovered, the mean health utility estimate of 0.66 at 18 months after fracture (compared to 0.75 prior to fracture) show that, on average, hip fractures result in substantial and persistent long-term loss in HRQoL. In addition, the mean hospital length of stay of 17.2 days suggests that hip fractures are associated with substantial costs to society.

References

1. Dolan, P., Modeling valuations for EuroQol health states. Med Care, 1997. 35(11): p. 1095-108.


Disclosure:

M. Ivergård,

OptumInsight,

3;

V. Wintzell,

OptumInsight,

3;

L. B. Tankó,

Novartis Pharma AG,

3;

V. Barghout,

Novartis Pharma AG,

5;

A. Svedbom,

OptumInsight,

3;

V. Alekna,

ICUROS,

2;

M. L. Bianchi,

ICUROS ,

2;

P. Clark,

ICUROS ,

2;

M. Díaz Curiel,

ICUROS,

2;

H. P. Dimai,

ICUROS ,

2;

M. Jürisson,

ICUROS,

2;

O. Lesnyak,

ICUROS,

2;

E. McCloskey,

ICUROS,

2;

K. M. Sanders,

ICUROS,

2;

T. Thomas,

ICUROS,

2;

F. Borgström,

ICUROS,

2;

J. A. Kanis,

ICUROS,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-quality-of-life-and-resource-use-related-to-hip-fractures-based-on-data-from-the-international-costs-and-utilities-related-to-osteoporotic-fractures-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology